Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.44 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6215219 | 0.88 | NPY5R (0.46) | OTUD7BNPY5RUSP30CCNE1CDK2 | |
| SCHEMBL6216418 | 0.83 | NPY5R (0.45) | NPY5RCCNE1CDK2CDK5ALDH1A1 | |
| SCHEMBL27567730 | 0.79 | HSD17B10 (0.53) | OTUD7BNPY5RUSP30ALDH1A1MAPT | |
| SCHEMBL23719175 | 0.77 | NPC1 (0.54) | OTUD7BNPY5RUSP30CDK2KMT2A | |
| SCHEMBL5997254 | 0.75 | CDK5 (0.63) | CCNE1CDK2CDK5ALDH1A1MAPT | |
| SCHEMBL31286005 | 0.72 | RAB9A (0.59) | ALDH1A1MAPTGAAKMT2AKDM4E | |
| SCHEMBL1011540 | 0.72 | RAB9A (0.59) | ALDH1A1MAPTGAAKMT2AKDM4E | |
| SCHEMBL7244914 | 0.71 | ALDH1A1 (0.56) | CCNE1CDK2CDK5ALDH1A1MAPT | |
| SCHEMBL5378517 | 0.70 | ACVR1 (0.44) | OTUD7BNPY5RUSP30WDR5CPB1 | |
| SCHEMBL32672110 | 0.70 | ALDH1A1 (0.48) | CCNE1CDK2CDK5ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1129089-B1 | SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20040063942-A1 | Spiro-indolines as Y5 receptor antagonists | MERCK & CO., INC. | 2004-04-01 | — | — | US | disclosed |
| US-6638942-B1 | Useful in the treatment of obesity and the complications associated therewith. | MERCK & CO., INC. | 2003-10-28 | — | — | US | disclosed |
| EP-1129089-A4 | SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6495559-B2 | FOR THERAPY OF OBESITY | MERCK & CO., INC. | 2002-12-17 | — | — | US | disclosed |
| US-20020058813-A1 | Spiro-indolines as Y5 receptor antagonists | MSD K.K. (JP) | 2002-05-16 | — | — | US | disclosed |
| US-6313298-B1 | OBESITY, DIETETICS; NEUROPEPTIDE Y ANTAGONISTS | MERCK & CO., INC. | 2001-11-06 | — | — | US | disclosed |
| EP-1129089-A1 | SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 2001-09-05 | — | — | EP | disclosed |
| US-6191160-B1 | DIETETICS | MERCK & CO., INC. | 2001-02-20 | — | — | US | disclosed |
| WO-2000027845-A1 | SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063942-A1 | Spiro-indolines as Y5 receptor antagonists | NPY5R, NPY1R, NPY2R | OTUD7B 4471/4885NPY5R 1/4885USP30 4732/4885 |
| US-20020058813-A1 | Spiro-indolines as Y5 receptor antagonists | NPY5R, NPY1R, NPY2R | OTUD7B 4493/4885NPY5R 1/4885USP30 4741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.